Authorized purpose: The TEX20, TEX10, TE X, and TE X Lite family provides mobile diagnostic ultrasound across broad adult, obstetric, pediatric, and neonatal applications; K212265 includes AI-based Smart Nerve visualization for interscalene and supraclavicular brachial plexus scouting, not live interventional guidance.
Clinical role
General and point-of-care ultrasound acquisition, measurement, analysis, and supported nerve visualization.
Images and patients
Ultrasound · Multi-region
Key limitation
Keep in mind: Smart Nerve is used to recognize the interscalene and supraclavicular brachial plexus. It is intended for visualization purpose only and not intended for live guidance during interventional procedure.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: The TEX20, TEX10, TE X, and TE X Lite family provides mobile diagnostic ultrasound across broad adult, obstetric, pediatric, and neonatal applications; K212265 includes AI-based Smart Nerve visualization for interscalene and supraclavicular brachial plexus scouting, not live interventional guidance.
Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Multi-region Input: Ultrasound image data and real-time data from a bedside device through X-Link.
Who uses it?Intended users: Competent healthcare professionals.
What does the software produce?Output: Ultrasound images, measurements of anatomical structures, analysis packages, and Smart Nerve visualization.
What is its most important limitation?Key limitation: Smart Nerve is used to recognize the interscalene and supraclavicular brachial plexus. It is intended for visualization purpose only and not intended for live guidance during interventional procedure.
Clinical takeaway. Clinical role: The TEX20, TEX10, TE X, and TE X Lite family provides mobile diagnostic ultrasound across broad adult, obstetric, pediatric, and neonatal applications; K212265 includes AI-based Smart Nerve visualization for interscalene and supraclavicular brachial plexus scouting, not live interventional guidance.
Evidence takeaway. Evidence from the reviewed source record: K212265 reports acoustic-output, biocompatibility, cleaning, electrical, mechanical, software, usability, and risk-management testing. The FDA summary identifies Smart Nerve as an AI feature but does not disclose a clinical dataset or numerical accuracy results.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
The TEX20, TEX10, TE X, and TE X Lite family provides mobile diagnostic ultrasound across broad adult, obstetric, pediatric, and neonatal applications; K212265 includes AI-based Smart Nerve visualization for interscalene and supraclavicular brachial plexus scouting, not live interventional guidance.
Exact FDA submission
Checked 2026-09-19
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
Ultrasound images, measurements of anatomical structures, analysis packages, and Smart Nerve visualization.
Exact FDA submission
Checked 2026-09-19
The exact packet supports image display, anatomical measurements, analysis packages, and Smart Nerve visualization; it does not state reports as an output.
Smart Nerve is used to recognize the interscalene and supraclavicular brachial plexus. It is intended for visualization purpose only and not intended for live guidance during interventional procedure.
Exact FDA submission
Checked 2026-09-19
This replaces the dossier's additional later-release qualification with the exact Smart Nerve boundary in the packet.
K212265 reports acoustic-output, biocompatibility, cleaning, electrical, mechanical, software, usability, and risk-management testing. The FDA summary identifies Smart Nerve as an AI feature but does not disclose a clinical dataset or numerical accuracy results.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
K212265 reports acoustic-output, biocompatibility, cleaning, electrical, mechanical, software, usability, and risk-management testing. The FDA summary identifies Smart Nerve as an AI feature but does not disclose a clinical dataset or numerical accuracy results.
Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.
Reported specificity
Not applicable
Not applicable
Not applicable
Checked 2026-09-03
Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K212265 FDA performance package for TEX20/TEX20 Pro/TEX20S/TEX20T/TEX20 Exp/TEX20 Elite Diagnostic Ultrasound System, TEX10/ TEX10 Pro/TEX10S/TEX10T/TEX10 Exp/TEX10 Elite/TE X/TE X Lite Diagnostic Ultrasound System
DesignManufacturer nonclinical system, software, acoustic-output, probe, safety, and usability verification
PopulationRepresentative adult, obstetric, pediatric, neonatal, and procedural ultrasound use conditions
Scopeexact submission
Tested versionTEX20/TEX10/TE X family release cleared in K212265
IndependenceSponsor or vendor study
K212265
Manufacturer evidence submitted for substantial equivalence; local clinical, technical, and workflow acceptance remains necessary.
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the device within the applicable imaging or surgical service line and verify payer, site-of-service, and coding assumptions independently.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Ultrasound image data and real-time data from a bedside device through X-Link.
Scope: Exact FDA submission. The exact packet supports ultrasound image data and bedside-device data through X-Link, but does not state the prior wired-or-wireless probe wording.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Ultrasound images, measurements of anatomical structures, analysis packages, and Smart Nerve visualization.
Scope: Exact FDA submission. The exact packet supports image display, anatomical measurements, analysis packages, and Smart Nerve visualization; it does not state reports as an output.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Ultrasound images, measurements of anatomical structures, analysis packages, and Smart Nerve visualization.
Scope: Exact FDA submission. The exact packet supports image display, anatomical measurements, analysis packages, and Smart Nerve visualization; it does not state reports as an output.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Mindray's Product Cybersecurity Whitepaper (November 2024) describes a product cybersecurity model for its devices covering governance and risk management, secure design and development (secure coding, security assessment and testing), protective measures (access control, system hardening), post-market vulnerability and patch management, incident logging and response, and data protection including data encryption and privacy impact assessment.
Vendor-wide
Checked 2026-10-27
Vendor whitepaper describing practices across Mindray products generally; no per-product annex read for the TEX20 series. Exact-release scope is not established.
Only competent physicians, sonographers, anesthesiology and critical-care clinicians, and trained ultrasound professionals. should operate or interpret the system. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Smart Nerve is limited to recognizing interscalene and supraclavicular brachial plexus for visualization and is not intended for live guidance during an intervention. Later TEX20 product-family features must not be attributed to K212265 without version mapping.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Smart Nerve is limited to recognizing interscalene and supraclavicular brachial plexus for visualization and is not intended for live guidance during an intervention. Later TEX20 product-family features must not be attributed to K212265 without version mapping.
exact submission · checked 2026-09-03
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-03
Vendor productivity claims are scenario inputs, not guaranteed local savings.
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Smart Nerve is limited to recognizing interscalene and supraclavicular brachial plexus for visualization and is not intended for live guidance during an intervention. Later TEX20 product-family features must not be attributed to K212265 without version mapping.
exact submission · checked 2026-09-03
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
27Fields reviewed
11Source classes checked
20Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains 20 PubMed and 0 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 20 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, vendor product page, reimbursement policy, fda device recall, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission
No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
Authorized purpose: Aplio i900, i800, and i700 software V9.0 are mobile diagnostic ultrasound systems for multi-region imaging. K252074 adds deep-learning 3rd Harmonic Imaging for abdominal images; with specified endoscopic transducers, the Aplio i800/E3 also supports imaging of the upper gastrointestinal tract, surrounding organs, airways, tracheobronchial tree, and esophagus.
Ge Medical Systems Ultrasound and Primary Care Diagnostics
Authorized purpose: LOGIQ E10s is a general-purpose diagnostic ultrasound system supporting the labeled adult, pediatric, cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal, urologic, and procedural applications.
Ge Medical Systems Ultrasound and Primary Care Diagnostics
Authorized purpose: LOGIQ E10 is a general diagnostic ultrasound system for qualified users across fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, breast, cardiac, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, and intraoperative applications.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.